NCT07316478 Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
| NCT ID | NCT07316478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Sickle Cell Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-01-15 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to determine whether a new stress management and mindfulness program can improve quality of life in individuals with sickle cell disease. The program is based on a number of empirically supported treatments including techniques from cognitive-behavioral therapy like overcoming motivational barriers to self-care, learning to see things as accurately as possible, practicing assertive communication, relaxation exercises like deep slow breathing, mindfulness meditation, and other stress management strategies.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older. * Diagnosed with sickle cell disease. * Live within 90 minutes of Philadelphia Exclusion Criteria: \- Severe depression or suicidality
Contact & Investigator
Melissa G Hunt, PhD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT07316478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sickle Cell Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07316478 currently recruiting?
Yes, NCT07316478 is actively recruiting participants. Contact the research team at mhunt@psych.upenn.edu for enrollment information.
Where is the NCT07316478 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07316478 clinical trial?
NCT07316478 is sponsored by University of Pennsylvania. The principal investigator is Melissa G Hunt, PhD at University of Pennsylvania. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.